1.1600
0.0000
(0.00%)
At close: January 24 at 4:00:00 PM EST
1.1500
-0.01
(-0.86%)
After hours: January 24 at 4:08:33 PM EST
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| BROUS TYLER Director | Purchase | Jun 28, 2024 | 238,088 |
| DEYOUNG CASI Officer | Stock Award(Grant) | Jan 10, 2024 | 91,497 |
| NEILL ANDREW R. Chief Financial Officer | Stock Award(Grant) | Jan 10, 2024 | 173,446 |
| PANDITE ARUNDATHY N. Officer | Stock Award(Grant) | Jan 10, 2024 | 219,280 |
| REDMILE GROUP, L.L.C. Director and Beneficial Owner of more than 10% of a Class of Security | Purchase | Dec 4, 2024 | -- |
| SCHREIBER TAYLOR M.D., PH.D. Chief Executive Officer | Purchase | Oct 7, 2024 | 2,681,750 |
| SHUKLA ABHINAV A. PH.D. Chief Technology Officer | Stock Award(Grant) | Jan 10, 2024 | 81,717 |
| STOUT STEPHEN General Counsel | Conversion of Exercise of derivative security | Mar 6, 2024 | 74,437 |
Related Tickers
FHTX Foghorn Therapeutics Inc.
4.0600
-7.31%
CCCC C4 Therapeutics, Inc.
3.6300
-2.94%
KYMR Kymera Therapeutics, Inc.
44.36
+0.29%
SPRB Spruce Biosciences, Inc.
0.3819
-0.37%
PRLD Prelude Therapeutics Incorporated
1.2150
+6.58%
CGEM Cullinan Therapeutics, Inc.
10.55
-0.09%
FULC Fulcrum Therapeutics, Inc.
4.1600
+0.48%
NRIX Nurix Therapeutics, Inc.
19.93
-0.15%
THTX Theratechnologies Inc.
1.7150
-0.29%
TRML Tourmaline Bio, Inc.
17.54
+0.17%